The following speakers have received an honorarium from Novo Nordisk for their input to and facilitation of this educational material:
- Prof. Aleksander Krag, University of Southern Denmark, Odense University Hospital
- Prof. Juan Mendive, Catalan Institute of Health, University of Barcelona
1. Abe RM, et al. Cureus. 2021;13:e16855
2. Sookoian S, Pirola CJ. Aliment Pharmacol Ther. 2017;46:85–95
3. Rinella ME, et al. Hepatology. 2023;77:1797–1835
4. EASL, EASD, EASO. J Hepatol. 2024; doi: 10.1016/j.jhep.2024.04.031
5. Cusi K, et al. Endocr Pract. 2022;28:528–562
6. Kawanaka M, et al. Intern Med. 2021;60:1397–1401
- To raise awareness of atypical forms of MASLD and MASH to support early identification of such patients
- To improve understanding of risk factors and comorbidities for MASLD/MASH
- To discuss optimal management of patients with atypical forms of MASLD/MASH, from diagnosis to treatment
